News

The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised ...
A vocal opponent of his predecessor Peter Marks, Vinay Prasad will now lead the office tasked with reviewing some genetic ...
Vinay Prasad, an academic and fierce critic of the medical mainstream, has been chosen to be the next director of the FDA ...
Dr. Vinay Prasad, the FDA's new vaccine chief, has been accused of spreading misinformation about Covid vaccines.
The firm notes Tuesday has been “a doozy of a day” for Sarepta, with the announcement of Vinay Prasad as the new head of the FDA’s CBER and a miss on Q1 earnings, where Elevidys net revenue came in ...
“Potential exposure to these substances is still quite small, thank goodness,” Jim Crotty, who served for over a decade in ...
Vinay Prasad, an oncologist-hematologist, has been appointed as the new director of the FDA's CBER, overseeing vaccines and ...
Controversial doctor Vinay Prasad, a public health researcher at UCSF known as a critic of US health policy, has been named ...